DS InPharmatics logoDS InPharmatics logoDS InPharmatics logoDS InPharmatics logo
  • HOME
  • ABOUT US
    • PHASE-APPROPRIATE EXPERTISE
    • YOUR TEAM
    • HISTORY
    • NEWS
    • EVENTS
    • CAREERS
    • PRODUCTLIFE GROUP
  • PARTNERS
    • PRODUCTLIFE GROUP
    • CILATUS BIOPHARMA CONSULTING
    • INTEGRITY
    • LIFEBEE
    • PHARMA IT
    • ZWIERS REGULATORY CONSULTANCY
  • SOLUTIONS
    • SMALL MOLECULE
    • BIOLOGICS CONSULTANTS
    • VETERINARY MEDICINE SOLUTIONS
    • CELLULAR AND GENE THERAPY
    • DUE DILIGENCE
    • REGULATORY AFFAIRS
    • CHEMISTRY MANUFACTURING CONTROLS
      • Drug Substance Services
      • Analytical Services
      • Drug Product Services
      • Supply Chain Services
    • QUALITY ASSURANCE
    • PROGRAM MANAGEMENT
  • INSIGHTS
    • RESOURCE LIBRARY
    • BLOG
    • 🎙️ CMC.LIVE
  • CONTACT US
  • HOME
  • ABOUT US
    • PHASE-APPROPRIATE EXPERTISE
    • YOUR TEAM
    • HISTORY
    • NEWS
    • EVENTS
    • CAREERS
    • PRODUCTLIFE GROUP
  • PARTNERS
    • PRODUCTLIFE GROUP
    • CILATUS BIOPHARMA CONSULTING
    • INTEGRITY
    • LIFEBEE
    • PHARMA IT
    • ZWIERS REGULATORY CONSULTANCY
  • SOLUTIONS
    • SMALL MOLECULE
    • BIOLOGICS CONSULTANTS
    • VETERINARY MEDICINE SOLUTIONS
    • CELLULAR AND GENE THERAPY
    • DUE DILIGENCE
    • REGULATORY AFFAIRS
    • CHEMISTRY MANUFACTURING CONTROLS
      • Drug Substance Services
      • Analytical Services
      • Drug Product Services
      • Supply Chain Services
    • QUALITY ASSURANCE
    • PROGRAM MANAGEMENT
  • INSIGHTS
    • RESOURCE LIBRARY
    • BLOG
    • 🎙️ CMC.LIVE
  • CONTACT US
  • BLOG
  • CAREERS
  • EVENTS
✕

Blog

November 1, 2021
Published by Meranda Parascandola at November 1, 2021

Microbiological Quality Considerations in Non-Sterile Drug Manufacturing

Mike Carroll, Quality Professional and Aseptic Processing specialist has an extensive history in microbiology and pharmaceuticals. One of his most recent commentaries is on Microbiological Quality Considerations in Non-Sterile Drug Manufacturing, a draft of guidance published in September of 2021
Do you like it?
Read more
Prev page
1...107108109110111...159
Next page

WHAT CAN DSI DO FOR YOU?



REGULATORY
AFFAIRS



CHEMISTRY
MANUFACTURING
CONTROLS



QUALITY
ASSURANCE

Tags

  • FDA
  • Regulatory Affairs
  • CMC
  • Drug Development
  • Breakthrough Designations
  • Sponsors
  • NDA
  • Drug Product
  • Regulatory Odd Couple Series
  • IND
  • ICH
  • CTD
  • Drug Substance
  • Analytical Methods
  • BLA
  • Regulatory Affairs
  • CMC
  • Quality Assurance
  • Expedited Drug Delivery
  • Whitepapers
  • Corporate Brochure
CONTACT

DS InPharmatics
a ProductLife Group Company
P.O. Box 532
Harleysville, PA 19438

PHONE

855-805-8402

EMAIL

solutions@dsinpharmatics.com

DS InPharmatics LLC

SITE MAP

DS InPharmatics LinkedIn
DS InPharmatics Twitter 
DS InPharmatics facebook
DS InPharmatics YouTube Channel
© 2026 DSI InPharmatics. All Rights Reserved.